SLC5A2 and diabetes mellitus: Among these, 125 common targets were shared among potential targets of SGLT2 inhibitors, known HF-related targets and DM-related targets by an online Venn diagram-drawing platform, seven of which came from actual patients with DM with HF in the studies (Fig. 3), In addition, 125 “drug-disease” common targets were introduced into Cytoscape v3.6.1 software to construct a visualized drug-target-disease network (Fig. 4).